secwatch / observer
8-K filed May 7, 2026, 7:59 PM ET ticker LFST CIK 0001845257
earnings confidence high sentiment positive materiality 0.80

LifeStance Q1 revenue up 21% to $403.5M; net income $14.2M; raises FY guidance

LifeStance Health Group, Inc.

item 2.02item 7.01item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001193125-26-209709
form_type
8-K
ticker
LFST
cik
0001845257
company_name
LifeStance Health Group, Inc.
filed_at
2026-05-07T23:59:59+00:00
discovered_at
2026-05-14T18:02:33.109768+00:00
generated_at
2026-05-14T22:01:03.107107+00:00
sec_items
["2.02", "7.01", "9.01"]
event_type
earnings
sentiment
positive
materiality_score
0.8
calibrated_materiality_score
0.8
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001193125-26-209709
json_url
https://secwatch.observer/filing/0001193125-26-209709.json
markdown_url
https://secwatch.observer/filing/0001193125-26-209709.md
text_url
https://secwatch.observer/filing/0001193125-26-209709.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1845257/000119312526209709/0001193125-26-209709-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1845257/000119312526209709/lfst-20260507.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Source-grounded claims

672fb2ca9af31560131be2bb0402d4078f201945

LifeStance Health Group, Inc. reported the first quarter ended March 31, 2026 results: revenue $403.5 million, net income $14.2 million. Guidance raised.

for the first quarter ended March 31, 2026. (All results compared to prior-year comparative period, unless otherwise noted) 2026 Highlights and FY 2026 Outlook • Revenue of $403.5 million increased 21% compared to revenue of $333.0 million • Clinician base increased 11% to 8,349 clinicians, a sequential net increase of 309 in the first quarter • First quarter

SEC 8-K Item 2.02 confidence 0.9 SEC evidence

Comparable filings

HPE

HPE Q2 FY26: record revenue $10.7B (+40%), raises FY26 guidance, introduces FY27 framework

Hewlett Packard Enterprise Co June 1, 2026, 4:09 PM ET earnings Items 1.01, 2.02, 5.02, 7.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

This filing

for the first quarter ended March 31, 2026. (All results compared to prior-year comparative period, unless otherwise noted) 2026 Highlights and FY 2026 Outlook • Revenue of $403.5 million increased 21% compared to revenue of $333.0 million • Clinician base increased 11% to 8,349 clinicians, a sequential net increase of 309 in the first quarter • First quarter

Comparable filing

gross margin, and non-GAAP diluted net EPS, as well as its highest-ever free cash flow generation for a second quarter. Second Quarter Fiscal 2026 Financial Results • Revenue : $10.7 billion, up 40% from the prior-year period • Gross margins : ◦ GAAP of 36.5%, up 810 basis points from the prior-year period and up 60 basis points sequentially ◦ Non-GAAP (1) of 36.9%,

Filing page SEC filing

ACH

Accendra Health Q1 revenue $627.8M, adj. EBITDA $58.4M; >$1.5B debt optimization

ACCENDRA HEALTH INC/VA/ May 11, 2026, 7:59 PM ET earnings Items 2.02, 7.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

This filing

for the first quarter ended March 31, 2026. (All results compared to prior-year comparative period, unless otherwise noted) 2026 Highlights and FY 2026 Outlook • Revenue of $403.5 million increased 21% compared to revenue of $333.0 million • Clinician base increased 11% to 8,349 clinicians, a sequential net increase of 309 in the first quarter • First quarter

Comparable filing

Commission this morning. ​ Details on First Quarter 2026 Results ​ ​ First Quarter Results (1) ​ ($ in millions, except per share data) ​ ​ ​ 1Q26 ​ ​ ​ 1Q25 Net Revenue ​ $ 627.8 ​ $ 673.9 ​ ​ ​ ​ ​ ​ ​ Loss from continuing operations, net of tax, GAAP ​ $ (6.5) ​ $ (3.8) Adj. net (loss) income from continuing operations, Non-GAAP ​ $ (3.1) ​ $ 23.2 ​ ​ ​

Filing page SEC filing

FSK

FSK posts Q1 GAAP loss of $1.57/sh, NAV falls to $18.83; announces $150M preferred, tender, buyback

FS KKR Capital Corp May 11, 2026, 7:59 PM ET earnings Items 1.01, 2.02, 7.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

This filing

for the first quarter ended March 31, 2026. (All results compared to prior-year comparative period, unless otherwise noted) 2026 Highlights and FY 2026 Outlook • Revenue of $403.5 million increased 21% compared to revenue of $333.0 million • Clinician base increased 11% to 8,349 clinicians, a sequential net increase of 309 in the first quarter • First quarter

Comparable filing

Earnings (Loss) per share of ($1.57), compared to Earnings (Loss) per share of ($0.41) for the quarter ended December 31, 2025

Filing page SEC filing

APC

ARKO Petroleum Q1 net income $8.1M ($4.5M), Adj. EBITDA $36.4M ($30.9M); completes IPO

ARKO Petroleum Corp. May 11, 2026, 7:59 PM ET earnings Items 2.02, 7.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

This filing

for the first quarter ended March 31, 2026. (All results compared to prior-year comparative period, unless otherwise noted) 2026 Highlights and FY 2026 Outlook • Revenue of $403.5 million increased 21% compared to revenue of $333.0 million • Clinician base increased 11% to 8,349 clinicians, a sequential net increase of 309 in the first quarter • First quarter

Comparable filing

announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 Key Highlights (vs. Year-Ago Period) 1,2 • Net income for the quarter increased to $8.1 million compared to $4.5 million. • Adjusted EBITDA for the quarter increased to $36.4 million compared to $30.9 million. • Net cash provided by operating activities for the quarter was

Filing page SEC filing

NESR

NESR Q1 revenue $404.6M (+33.5% YoY); net income $23.8M (+129%); EPS $0.23

National Energy Services Reunited Corp. May 11, 2026, 7:59 PM ET earnings Items 2.02, 7.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

This filing

for the first quarter ended March 31, 2026. (All results compared to prior-year comparative period, unless otherwise noted) 2026 Highlights and FY 2026 Outlook • Revenue of $403.5 million increased 21% compared to revenue of $333.0 million • Clinician base increased 11% to 8,349 clinicians, a sequential net increase of 309 in the first quarter • First quarter

Comparable filing

National Energy Services Reunited Corp. Reports First Quarter 2026 Financial Results ● Revenue for the quarter ended March 31, 2026, is $404.6 million, reflecting an increase of 33.5% year-over-year and 1.6% sequentially ● Net income for the quarter ended March 31, 2026, is $23.8 million, improving 205.4% sequentially and 129.3% year-over-year ● Diluted Earnings per Share (EPS) for the three months ended March 31, 2026 is $0.23, representing an increase of 109.1% year-over-year and 201.3% sequentially

Filing page SEC filing

SBET

Sharplink Q1 revenue $12.1M, net loss $685.6M; plans $125M Galaxy Onchain Yield Fund

Sharplink, Inc. May 11, 2026, 7:59 PM ET earnings Items 2.02, 7.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

This filing

for the first quarter ended March 31, 2026. (All results compared to prior-year comparative period, unless otherwise noted) 2026 Highlights and FY 2026 Outlook • Revenue of $403.5 million increased 21% compared to revenue of $333.0 million • Clinician base increased 11% to 8,349 clinicians, a sequential net increase of 309 in the first quarter • First quarter

Comparable filing

First Quarter 2026 Highlights Income Statement and Balance Sheet ● Total revenue increased materially to $12.1 million in Q1 2026, compared to $0.7 million for the three months ended March 31, 2025. The increase was primarily driven by the continued success of Sharplink’s actively managed ETH treasury strategy, which was launched on June 2, 2025. ● SG&A expenses were $9.9 million for the three months ended March 31, 2026, compared to $1.1 million in the prior year’s first quarter. The increase was primarily due to expenditures for investments in infrastructure, talent and systems required to scale and actively manage Sharplink’s institutional-grade ETH treasury platform. ● Net loss was $685.6 million in Q1 2026, compared to $1.0 million for the three months ended March 31, 2025.

Filing page SEC filing

PRTH

Priority Technology Q1 2026: Revenue $249.6M (+11.1% YoY), net income $9.8M (+18%)

Priority Technology Holdings, Inc. May 11, 2026, 7:59 PM ET earnings Items 2.02, 7.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

This filing

for the first quarter ended March 31, 2026. (All results compared to prior-year comparative period, unless otherwise noted) 2026 Highlights and FY 2026 Outlook • Revenue of $403.5 million increased 21% compared to revenue of $333.0 million • Clinician base increased 11% to 8,349 clinicians, a sequential net increase of 309 in the first quarter • First quarter

Comparable filing

• Revenue of $249.6 million increased 11.1% from $224.6 million, including organic growth of 9.1% • Gross profit of $93.5 million increased 13.2% from $82.6 million • Adjusted gross profit (a non-GAAP measure 2 ) of $98.8 million increased 13.2% from $87.3 million • Gross profit margin of 37.5% increased by nearly 70 basis points from 36.8% • Adjusted gross profit margin (a non-GAAP measure 2 ) of 39.6% increased by nearly 70 basis points from 38.9% • Operating income of $33.4 million increased 2.3% from $32.6 million • Net Income of $9.8 million increased 18.0% from $8.3 million • Adjusted EBITDA (a non-GAAP measure 2 ) of $58.1 million increased $6.8 million from $51.3 million • Diluted EPS of $0.12 increased by $0.02, or by 20%, from $0.10

Filing page SEC filing

CONSTELLATION ENERGY GENERATION LLC

Constellation Q1 adjusted EPS $2.74 beats prior year $2.14; affirms FY guidance $11-$12

CONSTELLATION ENERGY GENERATION LLC May 11, 2026, 7:59 PM ET earnings Items 2.02, 7.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

This filing

for the first quarter ended March 31, 2026. (All results compared to prior-year comparative period, unless otherwise noted) 2026 Highlights and FY 2026 Outlook • Revenue of $403.5 million increased 21% compared to revenue of $333.0 million • Clinician base increased 11% to 8,349 clinicians, a sequential net increase of 309 in the first quarter • First quarter

Comparable filing

GAAP Net Income of $4.49 per share and Adjusted (non-GAAP) Operating Earnings of $2.74 per share for the first quarter of 2026 • Affirming full year 2026 Adjusted Operating Earnings guidance of $11.00 - $12.00 per share

Filing page SEC filing

Source: SEC EDGAR
accession 0001193125-26-209709
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.